financetom
Business
financetom
/
Business
/
Investors cautiously welcome US-Europe trade deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Investors cautiously welcome US-Europe trade deal
Jul 27, 2025 12:09 PM

NEW YORK (Reuters) -Investors cautiously embraced news of a trade deal Sunday between the U.S. and European Union, a move that is expected to bring clarity for companies and some certainty to markets ahead of Friday's tariffs deadline.

U.S. President Donald Trump announced the United States has struck a framework trade deal with Europe.

The deal includes a 15% tariff on EU goods entering the U.S. and significant EU purchases of U.S. energy and military equipment.

"It's really in line with the Japan deal, and I assume investors will view it positively as they viewed the Japan deal," said Rick Meckler, partner at Cherry Lance Investments in New Vernon, New Jersey.

Optimism over easing trade tensions broadly helped push U.S. stocks to record highs last week and lifted European shares to their highest since early June. Trump's April 2 "Liberation Day" announcement of sweeping global tariffs sent stocks plunging in the immediate aftermath, due to spiking fears about a recession that have since faded.

Hopes for a deal with Europe were reinforced by Trump striking a trade agreement with Japan on July 23. 

Still, investors have been bracing for increased volatility heading into August 1, which the U.S. has set as a deadline for raising levies on a broad swath of trading partners.

"The two obvious reactions that you would expect are upside in the euro and upside in equity futures. I don't think equities in particular needed much of an excuse to rally and now they've got one," said Michael Brown, senior research strategist at Pepperstone in London.

The announcement came after European Commission President Ursula von der Leyen traveled to Scotland for talks with Trump to push a hard-fought deal over the line.

In the agreement with Japan, the country's auto sector, which accounts for more than a quarter of its U.S. exports, will see existing tariffs cut to 15% from levies totaling 27.5% previously.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Atlas Energy Solutions Q2 Net Income Falls, Sales Rise
Atlas Energy Solutions Q2 Net Income Falls, Sales Rise
Aug 5, 2024
05:45 PM EDT, 08/05/2024 (MT Newswires) -- Atlas Energy Solutions ( AESI ) reported Q2 net income late Monday of $0.13 per diluted share, down from $0.67 a year earlier. Analysts polled by Capital IQ expected $0.30. Sales for the quarter ended June 30 rose to $287.5 million from $161.8 million a year earlier. Analysts surveyed by Capital IQ expected...
Procter & Gamble Insider Sold Shares Worth $1,458,064, According to a Recent SEC Filing
Procter & Gamble Insider Sold Shares Worth $1,458,064, According to a Recent SEC Filing
Aug 5, 2024
05:44 PM EDT, 08/05/2024 (MT Newswires) -- Balaji Purushothaman, Chief Human Resources Officer, on August 01, 2024, sold 8,842 shares in Procter & Gamble ( PG ) for $1,458,064. Following the Form 4 filing with the SEC, Purushothaman has control over a total of 16,031 shares of the company, with 11,537 shares held directly and 4,494 controlled indirectly. SEC Filing:...
--Teradata Expects Cash Expenditure From Severance Payments of About $45 Million-$50 Million
--Teradata Expects Cash Expenditure From Severance Payments of About $45 Million-$50 Million
Aug 5, 2024
05:43 PM EDT, 08/05/2024 (MT Newswires) -- Price: 27.49, Change: -1.66, Percent Change: -5.69 ...
GSK wins latest trial over Zantac cancer claims
GSK wins latest trial over Zantac cancer claims
Aug 5, 2024
Aug 5 (Reuters) - GSK won the latest trial over claims that discontinued heartburn drug Zantac caused cancer, as a jury on Monday found that the drug was not responsible for an Illinois woman's illness, a company spokesperson said. Carrie Joiner had alleged in her lawsuit in state court in Chicago that she developed colorectal cancer from a carcinogenic contaminant...
Copyright 2023-2026 - www.financetom.com All Rights Reserved